Press Releases
Page 1 of 2
-
-
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
-
Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons
-
Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform
-
Alltrna Expands Leadership Team with Appointment of Joanne Protano as Chief Financial Officer